Exclusion based on Minimum Non Zero Concentrations [Design Issues]

posted by hiren379 – India, 2012-12-11 07:03 (4948 d 04:51 ago) – Posting: # 9708
Views: 4,056

❝ Check the literature of the drug, if the range of Tmax of your drug is very high and make sure that you didn't captured the sampling time points based on the Median Tmax rather than the Range.


Sampling time points were optimised based on all available literature to capture Cmax

❝ If the drug has rapid distribution phase simiar to Risedronate, you may get profile like this.


Rapid distribution is not reported. In other subjects such behaviour is not observed

If you have any other idea to tackle such situation please let me know ....

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
317 visitors (0 registered, 317 guests [including 13 identified bots]).
Forum time: 12:54 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5